Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Cash & Current Investments (2018 - 2025)

Health Catalyst (HCAT) has disclosed Cash & Current Investments for 8 consecutive years, with $91.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Current Investments fell 76.36% year-over-year to $91.5 million, compared with a TTM value of $91.5 million through Sep 2025, down 76.36%, and an annual FY2024 reading of $392.0 million, up 23.38% over the prior year.
  • Cash & Current Investments was $91.5 million for Q3 2025 at Health Catalyst, down from $97.3 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $455.2 million in Q3 2021 and bottomed at $91.5 million in Q3 2025.
  • Average Cash & Current Investments over 5 years is $332.3 million, with a median of $347.7 million recorded in 2023.
  • The sharpest move saw Cash & Current Investments soared 65.44% in 2021, then tumbled 76.36% in 2025.
  • Year by year, Cash & Current Investments stood at $445.0 million in 2021, then decreased by 18.31% to $363.5 million in 2022, then decreased by 12.59% to $317.7 million in 2023, then grew by 23.38% to $392.0 million in 2024, then plummeted by 76.65% to $91.5 million in 2025.
  • Business Quant data shows Cash & Current Investments for HCAT at $91.5 million in Q3 2025, $97.3 million in Q2 2025, and $342.0 million in Q1 2025.